Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022. ര Bioceres Crop Solutions Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-5 Consolidated statements of comprehensive income F-7 Consolidated statements of changes in equity F-9 Consolidated statements of cash flows F-10 Notes to the consolidated financial statements F-12 INDEX Consolidated f ...

Bioceres (NASDAQ: BIOX ) released 1Q25 results, with challenging topline and earnings results as a result of a slow beginning to the Argentinian campaign, which may be recovered in Q2. This affected the crop nutrition (beaded fertilizers) segment, with crop protection and seeds also posting negative toplineLong-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on ope ...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Q1 2025 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Paula Savanti – Head-Investor Relations Federico Trucco – Chief Executive Officer Enrique López Lecube – Chief Financial Officer Conference Call Participants Ben Klieve – Lake Street Capital Markets Kristen Owen – Oppenheimer Kemp Dolliver – Brookline Capital Markets Andrew Steinhardt – Canaccord Genuity Operator Good morning, ladies and gentlemen, and thank you for standing by. We ...

ര Bioceres Crop Solutions Fiscal First Quarter 2025 November / 2024 BIOCERES CROP SOLUTIONS This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or any of its affiliates, and shall not form the basis of any contract, nor shall it be construed in any manner as a commitment on the part of any person to procee ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION ...

For retail investors, momentum and trends can be drivers of investment decisions and interest. The stocks that analysts and other investors are talking about most may hold a special appeal (although timing the market and ensuring that you buy in at an appropriate time are difficult challenges). But many of the most popular stocks— companies including Apple Inc. NASDAQ: AAPL, Amazon.com Inc. NASDAQ: AMZN, and NVIDIA Corp. NASDAQ: NVDA—trade for well over $100 per share, making them inaccessible to some inves ...

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here's the latest list of major oversold players ...

Drs Producoes/E+ via Getty Images Bioceres (NASDAQ:BIOX) 4Q24 results disappointed the market, with the stock falling close to 15% after the release (and 30% since my last Hold article on the company). The main disappointment came from flattish profitability for the year, mostly caused by a decreasing business in crop nutrition in Q4. The generalized bear market in wheat, corn, and soybeans probably helped the pessimistic mood around Bioceres. Although the company continues advancing its HB4 products (with ...

ENDEAVOUR ACHIEVES COMMERCIAL PRODUCTION AT BIOX EXPANSION AND LAFIGUÉ GROWTH PROJECTS HIGHLIGHTS: • Commercial production achieved on budget and on schedule at the Sabodala-Massawa BIOX Expansion and the Lafigué mine on 1 August 2024 • Organic growth phase completed improving the quality of the portfolio and underpinning the transition to a phase focused on free cash flow generation • BIOX Expansion achieved commercial production; operating with 94% plant availability at 80% of nameplate capacity, with ave ...

�Bioceres Crop Solutions Fiscal Fourth Quarter & Full-Year September / 2024 BIOCERES CROP SOLUTIONS FOURTH QUARTER 2024 Disclaimer This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or any of its affiliates, and shall not form the basis of any contract, nor shall it be construed in any manner as a commitm ...